{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T17:21:47Z","timestamp":1762017707142,"version":"build-2065373602"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["N 3347CO-108792\/1"],"award-info":[{"award-number":["N 3347CO-108792\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s10620-019-05978-9","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T13:03:24Z","timestamp":1575378204000},"page":"2654-2663","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Lower Risk of B1-to-pB3-Stage Migration in Crohn\u2019s Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study"],"prefix":"10.1007","volume":"65","author":[{"name":"Swiss IBD Cohort Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9553-6486","authenticated-orcid":false,"given":"Patrick S.","family":"Cernoch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Zeitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Scharl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Morell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Greuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Schreiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Misselwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Safroneeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain M.","family":"Schoepfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan R.","family":"Vavricka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Rogler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Biedermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,3]]},"reference":[{"key":"5978_CR1","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/0016-5085(92)90029-X","volume":"103","author":"A Ekbom","year":"1992","unstructured":"Ekbom A, Helmick CG, Zack M, Holmberg L, Adami HO. Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology. 1992;103:954\u2013960.","journal-title":"Gastroenterology"},{"key":"5978_CR2","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1136\/gutjnl-2013-304766","volume":"63","author":"O Hovde","year":"2014","unstructured":"Hovde O, Kempski-Monstad I, Smastuen MC, et al. Mortality and causes of death in Crohn\u2019s disease: results from 20\u00a0years of follow-up in the IBSEN study. Gut. 2014;63:771\u2013775.","journal-title":"Gut"},{"key":"5978_CR3","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1053\/gast.2002.33632","volume":"122","author":"T Jess","year":"2002","unstructured":"Jess T, Winther KV, Munkholm P, Langholz E, Binder V. Mortality and causes of death in Crohn\u2019s disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Gastroenterology. 2002;122:1808\u20131814.","journal-title":"Gastroenterology"},{"key":"5978_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10620-014-3368-z","volume":"60","author":"DN Floyd","year":"2015","unstructured":"Floyd DN, Langham S, S\u00e9verac HC, Levesque BG. The economic and quality-of-life burden of Crohn\u2019s disease in Europe and the United States, 2000 to 2013: a systematic review. Dig Dis Sci. 2015;60:299\u2013312. https:\/\/doi.org\/10.1007\/s10620-014-3368-z.","journal-title":"Dig Dis Sci"},{"key":"5978_CR5","first-page":"141","volume":"5","author":"D Sachar","year":"1992","unstructured":"Sachar D, Andrews H, Farmer R, et al. Proposed classification of patient subgroups in Crohn\u2019s disease. Gastroenterol Int. 1992;5:141\u2013154.","journal-title":"Gastroenterol Int"},{"key":"5978_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.crohns.2009.12.003","volume":"4","author":"G Van Assche","year":"2010","unstructured":"Van Assche G, Dignass A, Panes J, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn\u2019s disease: definitions and diagnosis. J Crohns Colitis. 2010;4:7\u201327.","journal-title":"J Crohns Colitis"},{"key":"5978_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/00054725-200207000-00002","volume":"8","author":"J Cosnes","year":"2002","unstructured":"Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn\u2019s disease. Inflamm Bowel Dis. 2002;8:244\u2013250.","journal-title":"Inflamm Bowel Dis"},{"key":"5978_CR8","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/gut.49.6.777","volume":"49","author":"E Louis","year":"2001","unstructured":"Louis E, Collard A, Oger AF, Degroote E, Aboul NasrElYafi FA, Belaiche J. Behaviour of Crohn\u2019s disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001;49:777\u2013782.","journal-title":"Gut"},{"key":"5978_CR9","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1053\/gast.1996.v111.pm8780560","volume":"111","author":"JM Polito 2nd","year":"1996","unstructured":"Polito JM 2nd, Childs B, Mellits ED, Tokayer AZ, Harris ML, Bayless TM. Crohn\u2019s disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology. 1996;111:580\u2013586.","journal-title":"Gastroenterology"},{"key":"5978_CR10","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1053\/j.gastro.2005.12.019","volume":"130","author":"L Beaugerie","year":"2006","unstructured":"Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J. Predictors of Crohn\u2019s disease. Gastroenterology. 2006;130:650\u2013656.","journal-title":"Gastroenterology"},{"key":"5978_CR11","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/ecco-jcc\/jjv113","volume":"9","author":"L Biedermann","year":"2015","unstructured":"Biedermann L, Fournier N, Misselwitz B, et al. High rates of smoking especially in female Crohn\u2019s disease patients and low use of supportive measures to achieve smoking cessation-data from the Swiss IBD Cohort Study. J Crohns Colitis. 2015;9:819\u2013829.","journal-title":"J Crohns Colitis"},{"key":"5978_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/apt.14378","volume":"47","author":"BM Lang","year":"2018","unstructured":"Lang BM, Biedermann L, van Haaften WT, et al. Genetic polymorphisms associated with smoking behaviour predict the risk of surgery in patients with Crohn\u2019s disease. Aliment Pharmacol Ther. 2018;47:55\u201366.","journal-title":"Aliment Pharmacol Ther"},{"key":"5978_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/ecco-jcc\/jjv190","volume":"10","author":"V Annese","year":"2016","unstructured":"Annese V, Duricova D, Gower-Rousseau C, Jess T, Langholz E. Impact of new treatments on hospitalisation, surgery, infection, and mortality in IBD: a focus paper by the Epidemiology Committee of ECCO. J Crohns Colitis. 2016;10:216\u2013225.","journal-title":"J Crohns Colitis"},{"key":"5978_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.dld.2012.09.005","volume":"45","author":"C Gower-Rousseau","year":"2013","unstructured":"Gower-Rousseau C, Vasseur F, Fumery M, et al. Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD). Dig Liver Dis. 2013;45:89\u201394.","journal-title":"Dig Liver Dis"},{"key":"5978_CR15","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1136\/gutjnl-2013-306045","volume":"63","author":"C Gower-Rousseau","year":"2014","unstructured":"Gower-Rousseau C, Savoye G, Colombel JF, Peyrin-Biroulet L. Are we improving disease outcomes in IBD? A view from the epidemiology side. Gut. 2014;63:1529\u20131530.","journal-title":"Gut"},{"key":"5978_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1053\/j.gastro.2011.03.050","volume":"141","author":"GC Nguyen","year":"2011","unstructured":"Nguyen GC, Nugent Z, Shaw S, Bernstein CN. Outcomes of patients with Crohn\u2019s disease improved from 1988 to 2008 and were associated with increased specialist care. Gastroenterology. 2011;141:90\u201397.","journal-title":"Gastroenterology"},{"key":"5978_CR17","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/ajg.2014.97","volume":"109","author":"F Magro","year":"2014","unstructured":"Magro F, Rodrigues-Pinto E, Coelho R, et al. Is it possible to change phenotype progression in Crohn\u2019s disease in the era of immunomodulators? Predictive factors of phenotype progression. Am J Gastroenterol. 2014;109:1026\u20131036.","journal-title":"Am J Gastroenterol"},{"key":"5978_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/ajg.2016.524","volume":"112","author":"SF Jeuring","year":"2017","unstructured":"Jeuring SF, van den Heuvel TR, Liu LY, et al. Improvements in the long-term outcome of Crohn\u2019s Disease over the past two decades and the relation to changes in medical management: results from the population-based IBDSL Cohort. Am J Gastroenterol. 2017;112:325\u2013336.","journal-title":"Am J Gastroenterol"},{"key":"5978_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2165\/11586290-000000000-00000","volume":"24","author":"F Magro","year":"2010","unstructured":"Magro F, Portela F. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies. BioDrugs. 2010;24:3\u201314.","journal-title":"BioDrugs"},{"key":"5978_CR20","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/MCG.0000000000000338","volume":"50","author":"W Ferges","year":"2016","unstructured":"Ferges W, Rampertab SD, Shafqet M, et al. Experience with anti-TNF-\u03b1 biologic agents in succession in patients with Crohn\u2019s disease: a retrospective analysis of a single center. J Clin Gastroenterol. 2016;50:326\u2013330.","journal-title":"J Clin Gastroenterol"},{"key":"5978_CR21","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1053\/j.gastro.2008.07.069","volume":"135","author":"BG Feagan","year":"2008","unstructured":"Feagan BG, Panaccione R, Sandborn WJ, et al. Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn\u2019s disease: results from the CHARM study. Gastroenterology. 2008;135:1493\u20131499.","journal-title":"Gastroenterology"},{"key":"5978_CR22","doi-asserted-by":"publisher","first-page":"S-22","DOI":"10.1016\/S0016-5085(15)30079-2","volume":"148","author":"S Jeuring","year":"2015","unstructured":"Jeuring S, Van den Heuvel T, Zeegers M, et al. 79 Disease behavior in Crohn\u2019s disease patients diagnosed in the biological era: a Dutch population-based IBD-SL Cohort Study. Gastroenterology. 2015;148:S-22.","journal-title":"Gastroenterology"},{"key":"5978_CR23","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/ije\/dyn180","volume":"38","author":"V Pittet","year":"2009","unstructured":"Pittet V, Juillerat P, Mottet C, et al. Cohort profile: the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS). Int J Epidemiol. 2009;38:922\u2013931.","journal-title":"Int J Epidemiol"},{"key":"5978_CR24","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1097\/MEG.0000000000000896","volume":"29","author":"D Herzog","year":"2017","unstructured":"Herzog D, Fournier N, Buehr P, et al. Prevalence of intestinal complications in inflammatory bowel disease: a comparison between paediatric-onset and adult-onset patients. Eur J Gastroenterol Hepatol. 2017;29:926\u2013931.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"5978_CR25","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1097\/MIB.0000000000000123","volume":"20","author":"CN Manser","year":"2014","unstructured":"Manser CN, Frei P, Grandinetti T, et al. Risk factors for repetitive ileocolic resection in patients with Crohn\u2019s disease: results of an observational cohort study. Inflamm Bowel Dis. 2014;20:1548\u20131554.","journal-title":"Inflamm Bowel Dis"},{"key":"5978_CR26","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/apt.13363","volume":"42","author":"E Safroneeva","year":"2015","unstructured":"Safroneeva E, Vavricka SR, Fournier N, et al. Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn\u2019s disease. Aliment Pharmacol Ther. 2015;42:977\u2013989.","journal-title":"Aliment Pharmacol Ther"},{"key":"5978_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/ajg.2010.343","volume":"106","author":"SR Vavricka","year":"2011","unstructured":"Vavricka SR, Brun L, Ballabeni P, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106:110\u2013119.","journal-title":"Am J Gastroenterol"},{"key":"5978_CR28","first-page":"28","volume":"2011","author":"C Jackson","year":"2011","unstructured":"Jackson C. Multi-state models for panel data: the MSM package for R. J Stat Softw. 2011;2011:28.","journal-title":"J Stat Softw"},{"key":"5978_CR29","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","volume":"140","author":"J Cosnes","year":"2011","unstructured":"Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785\u20131794.","journal-title":"Gastroenterology"},{"key":"5978_CR30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.cgh.2012.10.038","volume":"11","author":"M Camus","year":"2013","unstructured":"Camus M, Seksik P, Bourrier A, et al. Long-term outcome of patients with Crohn\u2019s disease who respond to azathioprine. Clin Gastroenterol Hepatol. 2013;11:389\u2013394.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5978_CR31","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1136\/gutjnl-2011-301971","volume":"61","author":"J Cosnes","year":"2012","unstructured":"Cosnes J, Bourrier A, Nion-Larmurier I, Sokol H, Beaugerie L, Seksik P. Factors affecting outcomes in Crohn\u2019s disease over 15 years. Gut. 2012;61:1140\u20131145.","journal-title":"Gut"},{"key":"5978_CR32","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/S0140-6736(17)30317-3","volume":"389","author":"S Kugathasan","year":"2017","unstructured":"Kugathasan S, Denson LA, Walters TD, et al. Prediction of complicated disease course for children newly diagnosed with Crohn\u2019s disease: a multicentre inception cohort study. Lancet. 2017;389:1710\u20131718.","journal-title":"Lancet"},{"key":"5978_CR33","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/s41395-018-0108-6","volume":"113","author":"LE Targownik","year":"2018","unstructured":"Targownik LE, Leung S, Lix LM, Singh H, Bernstein CN. Persistence with immunomodulator monotherapy use and incidence of therapeutic ineffectiveness among users of immunomodulator monotherapy in IBD. Am J Gastroenterol. 2018;113:1206\u20131216.","journal-title":"Am J Gastroenterol"},{"key":"5978_CR34","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1053\/j.gastro.2013.04.048","volume":"145","author":"J Cosnes","year":"2013","unstructured":"Cosnes J, Bourrier A, Laharie D, et al. Early administration of azathioprine vs conventional management of Crohn\u2019s Disease: a randomized controlled trial. Gastroenterology. 2013;145:758\u2013765.","journal-title":"Gastroenterology"},{"key":"5978_CR35","doi-asserted-by":"publisher","first-page":"e761","DOI":"10.1053\/j.gastro.2013.06.009","volume":"145","author":"J Pan\u00e9s","year":"2013","unstructured":"Pan\u00e9s J, L\u00f3pez-Sanrom\u00e1n A, Bermejo F, et al. Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn\u2019s disease. Gastroenterology. 2013;145:e761.","journal-title":"Gastroenterology"},{"key":"5978_CR36","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1053\/j.gastro.2013.07.041","volume":"145","author":"AD Frolkis","year":"2013","unstructured":"Frolkis AD, Dykeman J, Negr\u00f3n ME, et al. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology. 2013;145:996\u20131006.","journal-title":"Gastroenterology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05978-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-019-05978-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05978-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:46:13Z","timestamp":1606869973000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-019-05978-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,3]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["5978"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-05978-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2019,12,3]]},"assertion":[{"value":"14 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}